---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-052055"
form_type: "8-K"
ticker: "GLUE"
cik: "0001826457"
company_name: "Monte Rosa Therapeutics, Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:50:20.001117+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Monte Rosa CSO Owen Wallace departs May 17 to become CEO at UK biotech; remains adviser

## Summary
- Owen Wallace resigns as CSO effective May 17, 2024, to become CEO of a UK-based biotech company.
- Departure is not due to any disagreement with Monte Rosa or its board; will continue as scientific adviser on SAB.
- Drug discovery led by Sharon Towson (CTO), John Castle (CDIO), and Magnus Walter (SVP Drug Discovery).
- Company expects no disruption to ongoing MGD programs or drug discovery efforts.

## SEC filing metadata
- accession: 0000950170-24-052055
- form_type: 8-K
- ticker: GLUE
- cik: 0001826457
- company_name: Monte Rosa Therapeutics, Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826457/000095017024052055/0000950170-24-052055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826457/000095017024052055/glue-20240429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-052055
- JSON: https://secwatch.observer/filing/0000950170-24-052055.json
- Plain text: https://secwatch.observer/filing/0000950170-24-052055.txt

## Key facts
- Executive change
  Owen Wallace resigned as Chief Scientific Officer at Monte Rosa Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Scientific Officer
  source text: On April 29, 2024, Owen Wallace, the Chief Scientific Officer of Monte Rosa Therapeutics, Inc. (the "Company"), resigned from the Company effective May 17, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826457/000095017024052055/0000950170-24-052055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.